The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADAPTIMMUNE THERAPEUTICS SPONS ADR 00653A107 7,827 781,940 SH   SOLE   781,940 0 0
AVADEL PHARMACEUTICALS PLC SPONS ADR 05337M104 8,547 1,057,827 SH   SOLE   1,057,827 0 0
ALTIMMUNE INC COM NEW 02155H200 48,195 4,500,000 SH   SOLE   4,500,000 0 0
89BIO INC COM 282559103 5,802 291,140 SH   SOLE   291,140 0 0
CONSTELLATION PHARMACEUTICALS INC COM 210373106 120,707 4,016,873 SH   SOLE   4,016,873 0 0
KEROS THERAPEUTICS INC COM 492327101 25,218 672,306 SH   SOLE   672,306 0 0
KURA ONCOLOGY INC COM 50127T109 9,373 575,000 SH   SOLE   575,000 0 0
MARINUS PHARMACEUTICALS INC COM 56854Q101 14,545 5,726,540 SH   SOLE   5,726,540 0 0
MYOVANT SCIENCES LTD COM G637AM102 17,424 845,000 SH   SOLE   845,000 0 0
INARI MEDICAL INC COM 45332Y109 11,383 235,000 SH   SOLE   235,000 0 0
RELMADA THERAPEUTICS INC COM 75955J402 29,913 668,440 SH   SOLE   668,440 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105 9,273 625,710 SH   SOLE   625,710 0 0
SIERRA ONCOLOGY INC COM NEW 82640U404 4,585 378,888 SH   SOLE   378,888 0 0
SURFACE ONCOLOGY INC COM 86877M209 25,439 3,877,895 SH   SOLE   3,877,895 0 0
TRILLIUM THERAPEUTICS INC COM NEW 89620X506 54,931 6,790,000 SH   SOLE   6,790,000 0 0
VAXART INC COM NEW 92243A200 24,470 2,765,000 SH   SOLE   2,765,000 0 0